计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| N648450-1mg |
1mg |
现货 ![]() |
| |
| N648450-5mg |
5mg |
现货 ![]() |
| |
| N648450-10mg |
10mg |
现货 ![]() |
| |
| N648450-25mg |
25mg |
现货 ![]() |
| |
| N648450-50mg |
50mg |
现货 ![]() |
|
| 别名 | N-(2,6-二乙基苯基)-1-甲基-8-((4-((1-甲基哌啶-4-基)氨基甲酰基)-2-(三氟甲氧基)苯基)氨基)-4,5-二氢-1H-吡唑并[4,3-h]喹唑啉-3-羧酰胺 |
|---|---|
| 英文别名 | MPS1 Inhibitor | NMS-P715 | (N-(2,6-diethylphenyl)-1-methyl-8-({4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)phenyl}amino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide) |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | NMS-P715 |
| 生化机理 | NMS-P715 是一种选择性 ATP 竞争性 MPS1 抑制剂,其 IC 50 为 182 nM。 |
| 储存温度 | 避光,-20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
NMS-P715 is a selective, ATP-competitive inhibitor of MPS1 , with an IC 50 of 182 nM. In Vitro NMS-P715 is a selective inhibitor of MPS1, with an IC 50 of 182 nM. NMS-P715 is highly specific for MPS1, with no other kinases inhibited below an IC 50 value of 5 μM and only 3 kinases inhibited below 10 μM (CK2, MELK, and NEK6). NMS-P715 promotes massive spindle assembly checkpoint (SAC) override with an EC 50 of 65 nM. NMS-P715 (1 μM) causes mitotic acceleration in U2OS cells overexpressing YFP-α-tubulin, induces aneuploidy and inhibits the proliferation of HCT116 cells. NMS-P715 (0.5, 1 μM) affects mitotic checkpoint complex (MCC) stability and cdc20 ubiquitylation. NMS-P715 (1 μM) exhibits bypass of the spindle assembly checkpoint and apoptosis in pancreatic ductal adenocarcinoma (PDAC) cell lines. NMS-P715 (0-25 μM) also selectively inhibits growth of PDAC cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo NMS-P715 (10 mg/kg) exhibits an oral bioavailability of 37% and good pharmacokinetic properties in nude mice bearing subcutaneous implanted human tumor cell xenografts. NMS-P715 (90 mg/kg, p.o.) is well tolerated and cuases no signs of body weight loss or other overt toxicities in an A2780 ovary carcinoma xenograft model. NMS-P715 (100 mg/kg, p.o.) inhibits the tumor growth by appr 43% in the A375 melanoma xenograft model . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:Mps1 182 nM (IC 50 ) CK2 5.7 μM (IC 50 ) MELK 6.01 μM (IC 50 ) NEK6 6.02 μM (IC 50 ) |
| 纯度 | ≥98% |
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | N-(2,6-diethylphenyl)-1-methyl-8-[4-[(1-methylpiperidin-4-yl)carbamoyl]-2-(trifluoromethoxy)anilino]-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide |
| INCHI | 1S/C35H39F3N8O3/c1-5-20-8-7-9-21(6-2)28(20)42-33(48)30-25-12-10-23-19-39-34(43-29(23)31(25)46(4)44-30)41-26-13-11-22(18-27(26)49-35(36,37)38)32(47)40-24-14-16-45(3)17-15-24/h7-9,11,13,18-19,24H,5-6,10,12,14-17H2,1-4H3,(H,40,47)(H,42,48)(H,39,41,43) |
| InChi Key | JFOAJUGFHDCBJJ-UHFFFAOYSA-N |
| Smiles | CCC1=C(C(=CC=C1)CC)NC(=O)C2=NN(C3=C2CCC4=CN=C(N=C43)NC5=C(C=C(C=C5)C(=O)NC6CCN(CC6)C)OC(F)(F)F)C |
| Isomeric SMILES | CCC1=C(C(=CC=C1)CC)NC(=O)C2=NN(C3=C2CCC4=CN=C(N=C43)NC5=C(C=C(C=C5)C(=O)NC6CCN(CC6)C)OC(F)(F)F)C |
| MeSH Entry Terms | N-(2,6-diethylphenyl)-1-methyl-8-((4-((1-methylpiperidin-4-yl)carbamoyl)-2-(trifluoromethoxy)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide;NMS P715;NMS-P715 |
| 分子量 | 676.73 |
| 溶解性 | DMSO : 2 mg/mL (2.96 mM; Need ultrasonic) |
|---|---|
| 敏感性 | 对光线敏感 |
| 分子量 | 676.700 g/mol |
| XLogP3 | 6.200 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 11 |
| 可旋转键计数Rotatable Bond Count | 9 |
| 精确质量Exact Mass | 676.31 Da |
| 单同位素质量Monoisotopic Mass | 676.31 Da |
| 拓扑极表面积Topological Polar Surface Area | 126.000 Ų |
| 重原子数Heavy Atom Count | 49 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 1110.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |